person · Reporting owner

Martin Celine Christine

Disclosed activity across 2 companies

Tapewire entity: 30255
SEC CIK: 0002092680

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
CONMED CorpCNMD · Entity 4691	Director	July 01, 2026	July 02, 2026
FULLER H B COFUL · Entity 4255	Director	September 30, 2026	October 01, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

CONMED Corp

Report date July 01, 2026 · Filed July 02, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
RSUs (Restricted Stock Units)SEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2036-07-01	Direct	5,603	Reported balance After 2026-07-01 transaction · row 1 Instrument identity requires review; Table II rows are not merged. 1 source row Row 1 · 2026-07-01 · Grant · Acquired 5,603 · Balance 5,603 F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting 100% after a one year period.

Filing footnotes · ownership attribution and instrument terms

F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting 100% after a one year period.

FULLER H B CO

Report date September 30, 2026 · Filed October 01, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	464.599	Reported balance After 2026-09-30 transaction · row 1 1 source row Row 1 · 2026-09-30 · Purchase · Acquired 464.599 · Balance 464.599 F1: The price reported is the weighted average purchase price for the transaction reported. The prices received were 464 shares at $49.50 and .599 share at $49.51.
Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2028-12-01	Direct	1,310.03	Reported balance Holding disclosure · report date 2026-09-30 · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · Balance 1,310.03 F2: These restricted stock units convert into shares of common stock on a 1-for-1 basis. F3: Amount includes restricted stock units acquired pursuant to a dividend equivalent reinvestment feature.
Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00	Direct	2,906.53	Reported balance Holding disclosure · report date 2026-09-30 · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · Balance 2,906.53 F4: These units convert into shares of common stock on a 1-for-1 basis. F5: These units will be converted into shares of common stock upon retirement, death, disability or certain specified events, all as defined in such plan, subject to holding periods required by law.

Filing footnotes · ownership attribution and instrument terms

F1: The price reported is the weighted average purchase price for the transaction reported. The prices received were 464 shares at $49.50 and .599 share at $49.51.

F2: These restricted stock units convert into shares of common stock on a 1-for-1 basis.

F3: Amount includes restricted stock units acquired pursuant to a dividend equivalent reinvestment feature.

F4: These units convert into shares of common stock on a 1-for-1 basis.

F5: These units will be converted into shares of common stock upon retirement, death, disability or certain specified events, all as defined in such plan, subject to holding periods required by law.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
September 30, 2026 Filed Oct 1, 2026 22:04 UTC	FULLER H B CO FUL · Entity 4255	PurchaseCommon Stock	464.599	$49.50	$22,997.65	Disclosure SEC source: 0001225208-26-008045 · doc4.xml · nonDerivative · entry 1 Martin Celine Christine · CIK 0002092680 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 464.599 F1 · price: The price reported is the weighted average purchase price for the transaction reported. The prices received were 464 shares at $49.50 and .599 share at $49.51. Read SEC document
July 15, 2026 Filed Jul 16, 2026 20:18 UTC	FULLER H B CO FUL · Entity 4255	GrantStock Units · Derivative	2,894.74	$57.00 Strike: $0.00	$165,000.18	Disclosure SEC source: 0001225208-26-006627 · doc4.xml · derivative · entry 1 Martin Celine Christine · CIK 0002092680 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,894.74 Underlying: Common Stock · 2,894.74 shares Expires not disclosed F1 · derivative.exercise_price: These units convert into shares of common stock on a 1-for-1 basis. F2 · derivative.exercise_date: These units will be converted into shares of common stock upon retirement, death, disability or certain specified events, all as defined in such plan, subject to holding periods required by law. F2 · derivative.expiration_date: These units will be converted into shares of common stock upon retirement, death, disability or certain specified events, all as defined in such plan, subject to holding periods required by law. Read SEC document
July 01, 2026 Filed Jul 2, 2026 21:15 UTC	CONMED Corp CNMD · Entity 4691	GrantRSUs (Restricted Stock Units) · Derivative	5,603	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0000816956-26-000087 · form4.xml · derivative · entry 1 Martin Celine Christine · CIK 0002092680 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,603 Underlying: Common Stock · 5,603 shares Expires 2036-07-01 F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document
January 26, 2026 Filed Jan 28, 2026 16:23 UTC	FULLER H B CO FUL · Entity 4255	GrantRestricted Stock Units · Derivative	1,300	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001225208-26-000988 · doc4.xml · derivative · entry 1 Martin Celine Christine · CIK 0002092680 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,300 Underlying: Common Stock · 1,300 shares Expires 2029-01-26 F1 · derivative.exercise_price: These restricted stock units convert into shares of common stock on a 1-for-1 basis. F1 · price: These restricted stock units convert into shares of common stock on a 1-for-1 basis. F2 · derivative.exercise_date: These restricted stock units vest in three annual installments (33%, 33%, and 34%) beginning on the date shown. Read SEC document
January 26, 2026 Filed Feb 4, 2026 21:13 UTC Amendment	FULLER H B CO FUL · Entity 4255	GrantRestricted Stock Units · Derivative	1,300	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001225208-26-001302 · doc4a.xml · derivative · entry 1 Martin Celine Christine · CIK 0002092680 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,300 Underlying: Common Stock · 1,300 shares Expires 2028-12-01 F1 · derivative.exercise_price: These restricted stock units convert into shares of common stock on a 1-for-1 basis. F1 · price: These restricted stock units convert into shares of common stock on a 1-for-1 basis. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.